SUMMARY To explore the relationship between blood pressure on the one hand and body composition variables and fat cell size and number on the other, these factors were determined in a population sample (n = 120) of 49-year-old men with blood pressure (BP) ranging from very low to very high. BP increased linearly with body weight throughout the entire BP range, while body fat and fat cell size increased with increasing BP in the nonhypertensive but not in the hypertensive BP range. Body cell mass and fat cell number were unrelated to BP. Fat cell size (but not fat cell number) was positively correlated with most variables of glucose metabolism.
B
LOOD pressure (BP) has been shown to be associated with body weight through a positive relationship between body fat and BP.
l-t Body fat mass is dependent on the number of tissue fat cells and/or their size. In moderate adult onset obesity, fat cell enlargement is a more important factor than increased fat cell number. 5 Whether obesity associated with essential hypertension is predominantly due to enlarged fat cells, hypertrophic obesity, or to increased number of fat cells, hyperplastic obesity, is not known.
We have determined body composition and adipose fat cell size and number in randomly selected middleaged men covering the whole BP range, in an attempt to clarify whether BP is related to fat cell size, fat cell number, or both. Glucose metabolism has also been studied in order to see whether increased fat cell size in essential hypertensives is associated with the same metabolic derangements as previously shown in normal men. 5 From the Department of Medicine I, University of Goteborg, Goteborg. Sweden.
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Methods

Study Population
A random half of all 49-year-old men living in Goteborg was invited to a screening examination of BP. Of the 3205 subjects invited, 2376 (74%) attended. Based on the subject's diastolic BP (DBP) at screening, we randomly selected 1/30 of those with a DBP < 95 mmHg(n = 23); 1/15 of those with a DBP 95-104 mm H g ( n = 15); 1/6 of those with a DBP 105-114 mm Hg (n = 15); and all those with a DBP =s 115 mm Hg (n = 67). The expected number of subjects in the various DBP groups had been calculated from the DBP distributions of earlier screening examinations of middle-aged men in Goteborg.
A further 59 subjects fulfilled the selection criteria; 36 of these subjects were not included in the study because they were on antihypertensive treatment. Another eight were excluded because of diseases influencing some of the variables studied (valvular heart disease, n = 4; previous myocardial infarction, n = 1; previous stroke, n = l ; chronic glomerulonephritis, n = 1; and severe alcoholism, n = 1), and 15 subjects refused to participate in further investigation. There were 120 subjects who remained for the study, i.e. 88.9% (120/135) of those asked to participate.
Study Protocol
The screening examination took place from March to May and from September to November, between 4:30 and 7:00 p.m. During the study the subjects were on unrestricted diet and remained outpatients. Initially, a 3-day urine collection was done for determination of urinary electrolytes and catecholamines. Thereafter, renal function, cardiac function, and metabolic and hormonal variables were studied, and a diagnostic examination was carried out for exclusion of secondary hypertension. These data will be presented separately.
Blood Pressure
The BP was measured in the right arm. The DBP was recorded when the Korotkoff sounds disappeared (phase five). Mean arterial pressure (MAP) was calculated as the DBP + one-third of the pulse pressure. A rubber cuff, 35 cm long and 12 cm wide, was used in all subjects.
Casual Blood Pressure
The BP at screening and at the outpatient hypertension clinic was measured once using a mercury manometer with the subject in the seated position after a few minutes' rest. The BP was determined to the nearest 2 mm Hg.
Resting Blood Pressure
The BP was measured twice during very quiet conditions, after 45 minutes of recumbent rest in a soundproof room, using a rubber cuff that was automatically inflated and deflated and with a heart sound microphone taped over the right brachial artery. Simultaneous registrations were made of cuff pressure, Korotkoff sounds, and electrocardiogram. The resting BP was calculated to the nearest 1 mm Hg.
Body Cell Mass and Body Fat
Radioactive potassium ('"K) as a measure of body cell mass was determined in a whole-body counter in all subjects except one, who refused due to claustrophobia. Body cell mass was calculated from total body potassium according to the formula of Moore et al., 6 and body fat according to that of Forbes et al. 7 
Metabolic Studies
The men were examined metabolically after overnight fasting. They were asked not to smoke in the morning before or during blood sampling and to come to the laboratory with as little physical exercise as possible. An initial venous blood sample was taken into a heparinized tube for the analysis of blood glucose and plasma insulin. After drinking 100 g of glucose, insulin and glucose were again analyzed after 60 minutes. Blood glucose was analyzed using a glucose oxidase method (Glox, Kabi, Stockholm, Sweden), and plasma insulin was determined using a commercially available radioimmunoassay (Phadebas, Pharmacia, Uppsala, Sweden). Data in the fasting state were available for 119 subjects and data after the load for 118.
Fat cell diameter (FCD) was determined in shreds of subcutaneous adipose tissue obtained percutaneously from the abdominal wall below and to the right of the umbilicus. 8 The tissue was briefly fixed in formaldehyde, which allowed freeze-cutting without breakage and distortion of the cells. The FCD was then measured by microscopy in these slices, floating in an isotonic solution that prevents deformation of the cells. A sufficient number of fat cells were measured to obtain a normal distribution of diameters. This method has been found to have an error of multiple determinations of less than 3.7% in diameter determinations of human fat cells. Over a fairly extensive range of FCDs it agrees closely with the osmium fixation method of Hirsch and Gallian. 9 After calculation of the mean diameter and its standard deviation, an average fat cell volume was calculated as described by Goldrich. 10 Fat cell weight was then obtained by assuming a mean density of fat cells equal to that of human adipose tissue triglyceride (0.915 g/ml). Body fat mass divided by fat cell weight gave an estimate of the fat cell number.
Statistical Methods
Standard methods were used for calculation of mean (x) standard deviation (SD), Pearson's correlation coefficient (r), and Spearman's coefficient of rank correlation (R). The hypothesis of no linear corelation between two variables was tested using the correlation coefficients. Values of p < 0.05 were regarded as statistically significant. Only two-sided tests were used.
In addition, a "sliding mean value" method was used to describe the relationship between BP and other variables. The subjects were ranked from 1 to 120 by increasing mean arterial pressure (MAP) after rest and were then subgrouped. The first subgroup included Subjects 1 to 40 having the lowest MAP. The second subgroup included Subjects 2 to 41, the third subgroup Subjects 3 to 42, and so on. The mean values of MAP and another variable were calculated in each subgroup. The successive points were then joined to form continuous curves. The mean values changed very slowly, since one subgroup differed from the next by only two subjects.
Two extra subgroups including the 20 subjects with the lowest MAP and the 20 subjects with the highest MAP were compiled to illustrate the extreme values. These curves thus describe how the mean values of a variable on the y axis changes when BP on the x axis increases. This method was used to give a more dynamic description of how a variable changes with increasing BP.
The BP axis was arbitrarily divided into three ranges (MAP < 90, 90-99, and 5= 100 mm Hg) before data analyses, to enable correlation analysis between BP and another variable in different parts of the BP distribution. The same ranges were used in analyses of other variables in the same study group." 1 2 Correlations with MAP were calculated using the Spearman's coefficient of rank correlation, since this test does not require normally distributed variables. For plasma insulin concentrations and blood glucose concentrations during the glucose load, logarithmic transformation was used.
Results
Descriptive Data
Means and standard deviations for BP and heart rate at the outpatient hypertension clinic, body composition variables, metabolic findings, FCD, and fat cell number in the low, intermediate, and high BP groups are given in table 1. Systolic and diastolic BP, heart rate, weight, body fat, fasting insulin, and insulin 60 minutes after the oral glucose load increased with higher BP
Blood Pressure and Body Composition
The MAP seemed to increase linearly with increasing body weight throughout the entire BP range (R = 0.24; p < 0.05, fig. 1 upper panel) . The increase in BP with higher body weight could be entirely explained by an increase in BP with increasing body fat (R = 0.23; p < 0.05, fig. 1 middle panel) . Body cell mass was unrelated to MAP ( fig. 1, lower panel) . The BP and body weight were significantly and positively correlated in all three MAP ranges. The BP was, however, significantly related to body fat only in the lower 
FCN (x 10'°)
135 ± 13 148 ± 13 162 + 18 83 + 9.7 95 ± 9.8 103 ± 12 71 + 12 76 ± 11 75 + 9.1 176 ± 5.2 176 ± 6.1 176 ± 6.7 77 6 ± 9 6 82.4 ± 11 84.9 ± 13 33.8 ± 5.1 34.2 ± 4.0 34.7 ± 3.8 18.1 ± 6.5 22.2 ± 8.2 23.3 ± 9.5 4.6 ± 0.4 5.1 ± 1.0 4.6 ± 0.7 5.9 ± 2.3 7.9 ± 3.2 7.2 ± 2.7 9.9 ± 5.1 11.8 + 7.4 13.1 ± 8.9 68 4 ± 38 72.2 ± 39 80.7 + 41 83.8 ± 12 91.0 ± 1 3 89.9 ± 14 5.5 ± 3.5 5.4 ± 3.2 6.2 ± 3.0 BP = blood pressure; HR = heart rate; BCM = body cell mass; BF = body fat; FBS = fasting blood sugar, BS60' = blood sugar 60 minutes after 100 g glucose orally; FI = fasting plasma insulin; 160' = plasma insulin 60 minutes after 100 g glucose orally; FCD •= fat cell diameter; FCN = fat cell number. Values are means + SD. 
FIGURE 1. Plots of body weight (upper panel), body fat (middle panel), and body cell mass (lower panel) vs mean arterial blood pressure (MAP) at rest. Mean values (thick lines) and standard deviations (thin lines) are given. The dashed lines connect the small group (n = 20) having the lowest and highest blood pressure with the nearest group of 40 subjects. Spearman's coefficient of rank correlation (R) is also given. The vertical dashed lines are the limits for the lower, intermediate, and higher MAP range.
MAP range (R = 0.46, p < 0.01) while in the upper two MAP ranges BP did not increase further with increasing body fat (MAP = 90-99 mm Hg, R = 0.09, n.s.; MAP > 100 mm Hg, R = -0 . 2 2 , n.s.). BP was not significantly correlated with body cell mass in any of the three MAP-ranges.
Blood Pressure, Fat Cell Diameter, and Fat Cell Number The MAP and FCD were not significantly associated in the whole study group (fig. 2) . In the lower BPrange, however, MAP increased with increasing FCD (R = 0.33, p < 0.05). In the intermediate and higher BP ranges, MAP was not significantly related to FCD, and FCD did not increase further in these MAP ranges.
In the borderline group 23% (7/30) and in the hypertensive group 22% (11/50) had a FCD above the 95th percentile in the normotensive group (FCD = 100 /urn, fig. 2 ). At all BP levels, the MAP was unrelated to fat cell number. 
Interrelationships between Body Composition, Glucose Metabolism, and FCD
To study these interrelationships, correlation matrices were constructed separately for the nonhypertensive (MAP < 100 mm Hg) and hypertensive (MAP 3= I00 mm Hg) blood pressure ranges (table 1) . Body weight was significantly and positively correlated with most variables of glucose metabolism and also with FCD in both the nonhypertensive and hypertensive BP ranges (table 2) . Body fat was, as expected, positively associated with most variables of glucose metabolism in both these groups. Body cell mass was significantly and positively correlated with fasting insulin and FCD in both BP ranges.
Increased fat cell size was associated with an increased fasting insulin during the glucose load in both BP groups. It was significantly associated with an impaired glucose tolerance, however, only among nonhypertensives, and associated with an increased fasting blood glucose only in the hypertensive group. Fat cell number was not significantly related to variables of glucose metabolism in any of the two MAP ranges.
Discussion
This study was performed in an unselected population sample of untreated 49-year-old men, so as to exclude any influence due to variations in age, sex, or drugs, all factors known to influence the variables studied. Then, still using random methods, we added a Significant correlations are in bold face. BW = body weight; BF = body fat; BCM = body cell mass; FBS = fasting blood sugar; BS60' = blood sugar 60 minutes after 100 g glucose orally; FI = fasting plasma insulin; 160' = plasma insulin 60 minutes after 100 g glucose orally; FCD = fat cell diameter. refinement of subjects in the upper part of the BP range to enable a more valid description of changes in the borderline and definitely hypertensive ranges. The criteria for inclusion ensured that the subjects were representative for all BP levels. We used resting instead of casual MAP, as we have previously shown this pressure to better reflect the severity of the BP disease than other measurements. 13 This study has three main findings. First, the wellknown relationship between body weight and BP in middle-aged men was found to be caused by a positive relationship between body fat and BP. This has previously been shown in several studies, 2 " 4 and our results confirm this point. In the hypertensives, body fat was not associated with the level of BP.
Second, fat cell size but not fat cell number was positively related to BP in the normotensive range, implying that hypertrophic but not hyperplastic obesity is associated with increased risk of hypertension. One must remember, however, that hyperplastic obesity is uncommon in the body fat range examined here. 5 The relationship was confined to the normotensive range and did not seem to extend into the "hypertensive" part of the population. The finding of a positive correlation between fat cell size and BP in normal man has not, as far as we know, been presented before and extends present knowledge.
Third, as could be expected from previously published data, 5 the increase in fat cell size was associated with impaired glucose tolerance and hyperinsulinemia. This relationship extended into the hypertensive BP.
When interpreting our results, one must keep in mind that the presence of a significant correlation between two variables does not necessarily imply a cause-and-effect relationship. Furthermore, the important correlations were all fairly weak, and we want to point out that conclusions based on these correlations should be drawn carefully. The mechanisms behind the observed association betwen hypertrophic obesity and blood pressure could not be elucidated in this epidemiological, descriptive study. The first interesting point to notice is, however, that the influence of fat cell size on BP seems to vanish somewhere in the upper borderline BP range. We have shown the same phenomenon for the relationship between salt intake and BP. ' 2 Thus, the two factors that previous research have shown to be most strongly related to the development of hypertension, obesity and salt intake, might be operating only in the normotensive range. The explanation is probably that, as borderline or definite hypertension develops, secondary changes occur in the heart and resistance vessels 14 that thereafter are the main determinants of the BP level.
Our findings indicate that there might be common pathophysiological mechanisms behind the development of hypertension and obesity. A high caloric intake might cause obesity and hypertension either indirectly through the weight factor or through an increased sympathetic discharge. 15 " 17 Further studies are needed to clarify these common pathophysiological mechanisms.
The metabolic derangements studied here (present in roughly one-fourth of the hypertensive subjects) are probably associated with an increased risk of cardiovascular morbidity and mortality. They might, therefore, be factors responsible for the extremely variable prognosis in essential hypertension. The prognostic implications of these metabolic aberrations must, however, be studied prospectively. Today, we treat more than 10% of the middle-aged population for hypertension knowing very well that only a minority will benefit from the treatment. Thus, prognostic factors other than BP are greatly needed as tools for therapeutic guidance. Prospective studies into the role of metabolic derangements in hypertension should, therefore, be given high priority.
